Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Sangamo Therapeutics Inc (SGMO)

111 + Investors. Track Smart Money conviction in SGMO. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +8
Streak
1Q ▲
Buyers last Q
61%

Smart Money Signals — SGMO

Based on 112 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added SGMO than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
📊

High ownership — 81% of 3.0Y peak

81% of all-time peak
112 funds currently hold this stock — 81% of the 3.0-year high of 139 funds (reached 2023 Q2). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📉

Outflows — 7% fewer funds vs a year ago

fund count last 6Q
9 fewer hedge funds hold SGMO compared to a year ago (-7% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟢

More buyers than sellers — 61% buying

58 buying37 selling
Last quarter: 58 funds were net buyers (27 opened a brand new position + 31 added to an existing one). Only 37 were sellers (18 trimmed + 19 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+8 vs last Q)

new funds entering per quarter
Funds opening a new SGMO position: 15 → 17 → 19 → 27. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

52% of holders stayed for 2+ years

■ 52% conviction (2yr+) ■ 18% medium ■ 30% new
58 out of 112 hedge funds have held SGMO for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +74%, value +5%

Value
+5%
Shares
+74%
Last quarter: funds added +74% more shares while total portfolio value only changed +5%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📈

Growing discovery — still being found

25 → 15 → 17 → 19 → 27 new funds/Q
New funds entering each quarter: 15 → 17 → 19 → 27. A growing number of institutions are discovering SGMO each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Deep conviction — 59% of holders stayed 2+ years

■ 59% veterans ■ 12% 1-2yr ■ 29% new
Of 116 current holders: 68 (59%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
📋

Smaller funds dominant — 18% AUM from top-100

18% from top-100 AUM funds
23 of 112 holders rank in the top 100 by AUM, but together hold only 18% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
2.8
out of 10
Low Exit Risk
Exit risk score 2.8/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — SGMO

In 2026 Q1, 58 hedge funds were net buyers of SGMO (27 opened a new position, 31 added to an existing one), while 37 reduced or exited (18 trimmed, 19 sold completely) — a 61% buyer ratio, indicating clear institutional accumulation. Net fund flow last quarter: +8 funds (more new holders than closures). Total institutional holders: 112.

Hedge Fund Ownership: SGMO

How many hedge funds hold SGMO — quarterly history vs. share price
Quarterly hedge fund ownership of SGMO vs. share price

Market Analysis: SGMO

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: SGMO

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Sangamo Therapeutics Inc (SGMO) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much SGMO has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 75d ago
SGMO
-39.2%
XLV
+4.9%

SGMO outperformed XLV by -44.1% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 30d ago
SGMO
+7.1%
XLV
+6.0%

Since the filing became public, SGMO outperformed XLV by +1.1% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

11 top-rated funds 0 high-conviction
Consensus
4.7
/ 10
breadth
×
Elite
0.1
/ 10
conviction
Hedge Fund Positioning: SGMO
111 + Investors

Track Smart Money conviction in SGMO. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 111 104 6.73%
13F Shares 111M 64M 74.28%
Total Value $28M $27M 5.23%
New Positions 26 19 +7
Increased Positions 29 25 +4
Closed Positions 19 25 -6
Reduced Positions 18 34 -16
Total Calls 3 4 -25.0%
Total Puts 3 3 -
PUT/CALL Ratio 1.0 0.75 Neutral

Statistics: SGMO

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

111 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in SGMO. Verified SEC 13F-HR filings.

QUARTER:
Top 25 SGMO holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Luminus Management LLC 0.25% 1,681,089 $415K
2 Armistice Capital, LLC 0.18% 40,400,067 $10.0M
3 Sanders Morris Harris LLC 0.03% 668,000 $165K
4 Wealth Management Associates, Inc. 0.03% 295,800 $73K
5 Ikarian Capital, LLC 0.02% 1,218,671 $301K
6 Diametric Capital, LP 0.02% 353,477 $87K
7 Mak Capital One LLC 0.02% 561,538 $139K
8 R Squared Ltd 0.01% 89,866 $22K
9 Kelsey Financial, LLC 0.01% 42,000 $10K
10 Axiom Investment Management LLC 0.00% 25,375 $6K
11 NINE MASTS CAPITAL Ltd 0.00% 113,465 $28K
12 Two Sigma Advisers, LP 0.00% 4,343,255 $1.8M
13 Ascentis Independent Advisors 0.00% 180,500 $44K
14 Redhawk Wealth Advisors, Inc. 0.00% 119,400 $29K
15 Pacific Sun Financial Corp 0.00% 24,000 $6K
16 BXM Wealth LLC 0.00% 12,350 $3K
17 Rik Saylor Financial, INC. 0.00% 11,500 $3K
18 Cannon Advisors, Inc. 0.00% 11,750 $3K
19 Jacobs Levy Equity Management, Inc 0.00% 2,050,384 $506K
20 Sandbox Financial Partners, LLC 0.00% 24,833 $6K
21 Two Sigma Securities, LLC 0.00% 60,102 $15K
22 Balyasny Asset Management L.P. 0.00% 5,288,097 $1.3M
23 Renaissance Technologies LLC 0.00% 3,836,665 $947K
24 Two Sigma Investments, LP 0.00% 6,270,441 $1.5M
25 Prelude Capital Management, LLC 0.00% 53,779 $13K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Sangamo Therapeutics Inc (SGMO)

What does the Smart Money Trend signal show for SGMO?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added SGMO than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for SGMO?

More buyers than sellers — 61% buying: Last quarter: 58 funds were net buyers (27 opened a brand new position + 31 added to an existing one). Only 37 were sellers (18 trimmed + 19 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for SGMO holders?

Smaller funds dominant — 18% AUM from top-100: 23 of 112 holders rank in the top 100 by AUM, but together hold only 18% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held SGMO?

52% of holders stayed for 2+ years: 58 out of 112 hedge funds have held SGMO for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Sangamo Therapeutics Inc (SGMO) following the 2026 Q1 hedge fund 13F filings?

As of today, SGMO has moved +7.1% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of +1.1%. Since the quarter end (March 31, 2026), SGMO has gained -39.2% vs +4.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →